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Abstract 
Infections are common in people with dementia, and antibiotic use is widespread although highly variable 
across healthcare settings and countries. The few studies conducted to date which consider the appropriateness 
of antibiotic prescribing specifically for people with dementia focus on people with advanced dementia and 
suggest that much of the prescribing of antibiotics for these patients may be potentially inappropriate. We 
suggest that clinicians must consider a number of factors to determine appropriateness of antimicrobial 
prescribing for people with dementia, including the risks and benefits of assessing and treating infections, the 
uncertainty regarding the effects of antibiotics on patient comfort, goals of care and treatment preferences, 
hydration status, dementia severity, and patient prognosis. Future research should examine antibiotic prescribing 
and its appropriateness across the spectrum of common infections, dementia severities, care settings and 
countries, and should consider how antibiotic therapy should be considered in discussions regarding treatment 
preferences, goals of care and/or advance care planning, between clinicians, patients and families.  
 
Keypoints 
• Antibiotic use in people in dementia is influenced by a wide variety of clinical and non-clinical factors 
such as burden of treatment, illness severity and family preferences; 
• Antibiotic use may frequently be inappropriate, but in dementia, assessment of appropriateness is more 
difficult due to, for example, difficulties in diagnosis and communicating symptoms; 
• Future research may develop consensus guidelines on appropriate prescribing of antibiotics that may be 
contextualised locally 
 
 
 
  
3 
 
1. Introduction 
Dementia is an irreversible progressive neurodegenerative disorder in which widespread neuronal cell death 
results in decline across a range of cognitive domains including difficulties in memory, disturbances in 
language, psychosocial and psychiatric changes, loss of ability to recognise familiar people or common objects, 
and impairment in activities of daily living [1-3]. It has been renamed “major neurocognitive disorder” in the 
most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [3] in an effort to 
reduce stigma associated with dementia, to bring diagnostic guidelines into line with current clinical practice, 
and in recognition of earlier stages of cognitive decline as mild neurocognitive disorder (NCD) [4].  
There are many aetiological variants of dementia, distinguished by unique neuropathology and determined by 
the area or structure within the brain predominantly affected [5]. Alzheimer’s disease (AD) is the most common 
variant, followed by vascular dementia (VaD). There is considerable overlap between AD and VaD; the amyloid 
plaques and neurofibrillary tangles associated with AD often co-exist with the multiple infarctions present in 
VaD and where this occurs, patients are diagnosed with mixed dementia [6,7]. Though AD and VaD are the 
most common variants to co-exist in mixed dementia, the term may be used to refer to the presence of two or 
more of any of the aetiological variants of dementia. Dementia with Lewy Bodies (DLB) and Frontotemporal 
Dementia (FTD) are less common variants which account for much smaller percentages of diagnosed cases.  
The World Alzheimer Report published in 2015 estimated that 46.8 million people worldwide are living with 
dementia, and this number is expected to almost double every 20 years, reaching 74.7 million in 2030 and 131.5 
million in 2050 [8]. Infections, including respiratory tract infections (RTIs), urinary tract infections (UTIs), and 
skin and soft tissue infections [9,10], are common in people with dementia. Treatment decisions for these 
vulnerable patients are often highly complex, particularly as dementia progresses and patients approach end of 
life [11], due to the inability of patients to communicate their symptoms as cognitive function declines, and 
because typical symptoms of infections are often absent [12,13]. Such decisions typically involve balancing 
potential benefits and burdens of treatment, patient and family preferences, the best interests of the patient and 
the risk of developing antibiotic resistant microbes [14-17]. A recent systematic review by van der Maaden and 
colleagues substantiated the view in the literature that decisions to start or withhold antibiotic treatment are 
challenging, identifying over 40 person- and context-related factors associated with antibiotic use in this 
population. The authors reported that these decisions are strongly influenced by country, healthcare context, and 
family and physician preferences [11]. 
The variability in antibiotic prescribing rates and practices across dementia severity, healthcare settings and 
countries may be due to the complexity of treatment decisions about antibiotics in dementia, in addition to 
limitations in certain care settings (such as the absence of diagnostic resources in long-term care environments) 
and a limited and somewhat contradictory evidence-base on the effects of antibiotic use [11,18,19].  The 
objectives of this narrative review are to consider the most common infections in people with dementia, and the 
treatment of such infections in this vulnerable patient group. We will also consider appropriate use (and misuse) 
of antimicrobials, and the variations in prescribing and care including at the end of life, with a particular focus 
on the long-term care setting to reflect the majority of the research literature in this area. Finally, we will make 
recommendations for practice and highlight research priorities for future studies in this area. 
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2. Infections in older people with dementia 
Immune senescence (age-associated changes in innate and adaptive immunity), physiological changes such as 
decreased nutritional status, development of swallowing difficulties and reduced mucociliary clearance, and 
frailty (defined as a state of increased vulnerability to poor resolution of homeostasis after a stressor event [20]), 
predispose older people to infection [21-23]. Furthermore, the aging process can complicate the diagnosis and 
treatment of infectious disease; fever and increased white cell counts tend to be less pronounced, and this can 
result in infections remaining undiagnosed [24]. Age-related changes in pharmacokinetics of antibiotics can 
alter absorption, distribution and elimination of these drugs, rendering treatment less effective or increasing the 
risk of toxicity [25-27]. As a consequence, older people are not only at increased risk of developing infections 
including lower respiratory tract infections (LRTIs, pneumonia), urinary tract infections (UTIs), and skin and 
soft tissue infections, but are also more likely to experience misdiagnosis and mismanagement [23]. Diagnosis is 
further complicated by the difficulty in obtaining good quality uncontaminated clinical specimens from older 
people, particularly from those who are unable to comply with the directions for obtaining such a sample. 
Although the risk of developing pneumonia is not significantly higher for people with dementia than for 
cognitively intact frail older people [28-30], diagnosis is more difficult, particularly in the more advanced stages 
of dementia, and risks of misdiagnosis and mismanagement are further increased. These individuals are more 
likely to experience delay in recognition of changes in status which would prompt assessment for infection, and 
have increased risk of mortality, both in general [31,32] or due to an infection [33-36]. A systematic review and 
meta-analysis to determine whether people with dementia were more likely to die from pneumonia as the 
immediate or underlying cause reported that the odds of pneumonia-associated mortality were increased more 
than two-fold for people with dementia [33]. Dysphagia has been recognised as a risk factor for pneumonia in 
people with dementia [37], and pneumonia and intake problems are important risk factors for mortality across 
all stages of dementia [9,38]. Studies focusing on advanced dementia have reported an association between 
dysphagia and aspiration pneumonia [39], and have demonstrated that pneumonia is significantly associated 
with shortened survival of nursing home residents [34,40]. It has been suggested that increased mortality of 
pneumonia in advanced dementia is associated with aspiration and weight loss [41], and with artificial feeding 
via the enteral route [42]. 
Antibiotics are widely prescribed for older people with dementia; most studies of prevalence of antibiotic use 
conducted to date consider the long-term care setting, with a smaller number examining hospital or community-
dwelling settings [11]. These studies assessed prevalence of antibiotic use in a variety of ways, including: point 
prevalence, period prevalence, antibiotic use in the last period before death, and antibiotic use during a specific 
infectious episode. Acknowledging the range of the methods used in the included studies, the authors reported 
that antibiotic use for people with dementia is often substantial but highly variable across healthcare contexts 
and countries. Point prevalence ranged from 3.3 to 16.6%, with period prevalence ranging from 4.4 to 88% 
overall, and from 23.5 to 94% in variable time frames before death. The median use was reported to be 52% for 
a median period of 14 days, and 48% for a median period of 22 days respectively. Antibiotics were prescribed 
for most patients with LRTIs or UTIs; between 77 and 91% of patients received treatment. The authors also 
found that more severe dementia was associated with lower rates of antibiotic use [11]. Poor prognosis was also 
associated with antibiotic use, and the direction of this association was dependent on the country of care. 
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Patients with a poor prognosis were more likely to receive antibiotics in studies conducted in the US [43,44] and 
across seven European countries and Israel [45]. Conversely people with a poor prognosis were more likely to 
not have antibiotics prescribed in the Netherlands [44]. 
3. Appropriateness of antibiotic use 
In considering antimicrobial prescribing for people with dementia, it is important to not only examine the 
prevalence of such prescribing but also whether it is appropriate. Prescribing is considered to be appropriate 
when medicines have a clear evidence-based indication, are cost-effective and well-tolerated [46]. Terms such 
as “inappropriate medication use”, “inappropriate drug use (IDU)”, “inappropriate prescribing (IP)” and 
“potentially inappropriate prescribing (PIP)” are used throughout the literature to refer to suboptimal prescribing 
practices which include misprescribing, overprescribing or underprescribing of medications [47,48].  A 
significant body of research exists which examines the appropriateness of antimicrobial use in older people 
residing in long-term care settings; however, there has been limited work undertaken to date which examines the 
appropriateness of antibiotic prescribing specifically in people with dementia [49,50].  
The few studies conducted to date which do consider appropriateness of antibiotic use in people with dementia 
focus on the advanced stages of disease; one study of US nursing home residents reported that 44% of suspected 
infectious episodes for which antimicrobials were prescribed met minimum clinical criteria [18], suggesting that 
much of the prescribing of antibiotics in advanced dementia may be unwarranted [50]. The authors concluded 
that antibiotics were most likely to be initiated in the absence of minimum treatment criteria for UTIs which rely 
on subjective signs and symptoms undetectable to the observer in the absence of patient self-report. They 
recognised that, while asymptomatic bacteriuria is the most common reason for potentially inappropriate 
antimicrobial prescribing in the nursing home setting, the interpretation of what is “symptomatic” in people in 
advanced dementia, and therefore the application of minimum criteria for treatment, are particularly challenging 
[50]. 
4. Recommendations for clinical practice 
In clinical practice, a number of factors must be taken into account when considering the appropriateness of 
antimicrobial treatment for this vulnerable patient group. Consideration should not be limited to whether 
treatment should be initiated. Further aspects must be considered, such as whether a particular medication 
should be chosen based on the infection being treated, and the local patterns of antimicrobial susceptibility and 
resistance, in addition to whether treatment should be changed or continued based on clinical response or results 
of culture and diagnostic testing, Length of treatment, route of administration (oral versus intravenous), and the 
wishes and preferences of the patient and their family are also important considerations in determining 
appropriateness of antimicrobial prescribing. 
Clinicians must take into account many factors when making decisions regarding antimicrobial prescribing for 
people with dementia.  Firstly, antibiotic therapy in the terminal stages of dementia prolongs survival in very 
few patients; indeed it has been argued that it may simply prolong the dying process [51,52]. Secondly, there is 
uncertainty as to whether antibiotics play a significant role in the maintenance of comfort in people with 
dementia suffering from pneumonia; a study of 323 nursing home residents with advanced dementia in 22 US 
nursing homes considered symptoms before, during and after pneumonia and reported that treatment with 
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antimicrobial agents does not improve comfort (symptom burden) of residents with advanced dementia who 
have pneumonia. It is important to note that in this study, comfort was assessed on one occasion during a three-
month period which included the episode of pneumonia. [53]. In contrast to the work by Volicer& Simard [51] 
and van der Steen et al. [52], Givens et al. [53] also reported prolonged survival among patients who received 
antibiotics compared to those for whom antibiotics were not prescribed. Others have argued that antibiotic 
treatment is associated with improved comfort [54], and more recent work suggests that antibiotics may not 
make a difference in comfort levels if effective symptom relief is provided [55]. Antibiotics may be prescribed 
because physicians and family members believe that antibiotics improve patient comfort [56,57]. Further, 
antibiotic use may be associated with significant adverse effects, such as gastrointestinal upset, allergic 
reactions, hyperkalaemia, and rarely, agranulocytosis; overuse may led to Clostridium difficile infection and 
development of antimicrobial resistance to treatment [51]. 
A decision to treat a patient with signs and symptoms suggestive of infection may not necessarily require the 
prescribing of antibiotic therapy. Such a decision may be made in the context of consideration of goals of care, 
or may be based on a conservative therapeutic approach involving watchful waiting, and may therefore be 
revisited as a patient is offered symptomatic relief and supportive care including pain management, skin care, 
and hydration. The interplay of the factors outlined above complicates the clinical decision-making process 
regarding appropriateness of antimicrobial therapy for this patient group. Decisions to prescribe or withhold 
antibiotics in advanced stages should take into consideration the risks and benefits of assessing and treating 
infections, the uncertainty regarding any significant benefits of treatment for patient comfort, and should align 
such considerations with goals of care [50,51]. If a decision is reached to withhold antibiotics, suspected 
infections should not be worked up, and symptoms treated using palliative measures alone [50]. 
Furthermore, clinicians must also bear in mind the hydration status of the patient due to its impact on the 
effectiveness of antibiotic therapy. Similar mortality rates have been reported for nursing home residents who 
had sufficient water intake whether or not they were prescribed antibiotics [51,52,58]. Conversely, in a two-
country study, antibiotics have been shown to be less effective for nursing home residents who had insufficient 
water intake, and mortality rates reported to be highest for residents who neither received antibiotics nor had 
sufficient water intake [58].  
Optimising the management of infections in people with dementia is of critical importance, requiring 
collaboration between geriatrics and infectious disease specialists, and in the more advanced stages of dementia, 
palliative care experts [59]. It should include patient and family counselling, clinical training and the 
development and/or utilisation of clinical algorithms to evaluate appropriateness of antimicrobial prescribing 
which take into consideration dementia severity, patient prognosis, goals and burden of care and treatment 
preferences as appropriate [17,59-61]. 
5. Research priorities 
To date, studies considering prevalence of antibiotic use in people with dementia have focused on people with 
advanced stages of the disease residing in long-term care or hospital settings, and have not considered common 
infections such as skin or soft tissue infections [11]. Further work examining antibiotic prescribing across the 
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spectrum of common infections (UTIs, LRTIs and skin and soft tissue infections), dementia severities, and care 
settings (long-term care, hospital and community-dwelling), is therefore a research priority.  
Studies examining the appropriateness of antibiotic prescribing for older people in nursing homes have used a 
number of different algorithms to date [62]; it has been suggested that a universally applicable instrument to 
facilitate international comparison should be developed, which accounts for country-specific practice variations 
and into which existing guidelines and articles on appropriate prescribing of antibiotics [63-68] and patient 
preference and prognosis [62] could be incorporated. Whilst these guidelines are not specific to people with 
dementia, it has been argued that in developing such an instrument, applicability should be ensured across long-
term care facilities and countries, and also in residents of such facilities with dementia [13]. Future research 
should therefore focus on the development of such an instrument, and should consider discussions between 
clinicians, patients and families regarding antibiotic treatment preferences, goals of care and/or advance care 
planning. There is also a need to define appropriate outcomes to be employed in randomised controlled trials of 
antimicrobials in people with dementia, particularly in relation to (dis)comfort measures.  
6. Conclusion 
Infections are common among people with dementia, and prescribing of antibiotics is prevalent, though highly 
variable across settings of care and across countries. The appropriateness of such prescribing has been neglected 
in the research literature to date. Further studies into prevalence and appropriateness of antibiotic prescribing 
across the spectrum of common infections, dementia severities, care settings and countries is a research priority. 
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